Sfoglia per AUTORE
BOSA C
Collezione AOU Città della Salute di Torino

  

Items : 11

Does Microbiome Matter in Chronic Intestinal Failure Due to Type 1 Short Bowel Syndrome in Adults? in Nutrients / Nutrients. 2024 Jul 16;16(14):2282. doi: 10.3390/nu16142282.
2024
AOU Città della Salute di Torino

Ossola M; Ferrocino I; Franciosa I; Aimasso U; Cravero L; Bonciolini A; Cardenia V; Merlo FD; Anrò M; Chiarotto A; Bosa C; Cocolin L; Bo S;

Long-term modifications of the peripheral immune repertoire after switching from sequestering disease-modifying treatments in multiple sclerosis. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2024 Dec;30(14):1737-1754. doi: 10.1177/13524585241284846. Epub 2024 Oct 7.
2024
AOU Città della Salute di Torino

Vercellino M; Marasciulo S; Ricotti E; Rolando A; Bosa C; Garelli P; Gallina V; Vaula G; Calvo A; Cavalla P;

Association of MRI leptomeningeal enhancement with disability worsening in progressive multiple sclerosis: A clinical and post-mortem study. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2023 Nov;29(13):1526-1539. doi: 10.1177/13524585231199031. Epub 2023 Sep 23.
2023
ASL Torino 5
AOU Città della Salute di Torino

Morana G; Calvo A; Rolando A; Garelli P; Valentini C; Bosa C; Marasciulo S; Sciortino P; Lequio L; De Negri F; Costantini G; Cogoni M; Cavalla P; Vercellino M;

SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2023 Jun;74:104715. doi: 10.1016/j.msard.2023.104715. Epub 2023 Apr 10.
2023
AOU Città della Salute di Torino

Vercellino M; Bosa C; Alteno A; Muccio F; Marasciulo S; Garelli P; Cavalla P;

Impact of COVID-19 lockdown on progressive multiple sclerosis patients. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2022 May;43(5):2943-2946. doi: 10.1007/s10072-022-05909-z. Epub 2022 Jan 24.
2022
AOU Città della Salute di Torino

Cavalla P; Marasciulo S; Petracca M; Schillaci V; Alteno A; Bosa C; Vercellino M;

Acute and chronic synaptic pathology in multiple sclerosis gray matter. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2022 Mar;28(3):369-382. doi: 10.1177/13524585211022174. Epub 2021 Jun 14.
2022
AOU Città della Salute di Torino

Corona C; Giordana MT; Chiò A; Casalone C; Crociara P; Pasanisi MB; Vallino-Costassa E; Bosa C; Grifoni S; Marasciulo S; Vercellino M; Cavalla P;

Dietary habits, nutritional status and risk of a first demyelinating event: an incident case-control study in a southern European cohort. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2022 Jul;43(7):4373-4380. doi: 10.1007/s10072-022-05908-0. Epub 2022 Feb 15.
2022
ASL Torino 5
AOU Città della Salute di Torino

Vercellino M; Cuffini E; Panizzolo S; De Francesco A; Chiò A; Costantini G; Durelli P; Alteno A; Schillaci V; Bosa C; Pasanisi MB; Cavalla P; Maietta D; Golzio P;

CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab. in International journal of environmental research and public health / Int J Environ Res Public Health. 2021 Aug 2;18(15):8163. doi: 10.3390/ijerph18158163.
2021
AOU Città della Salute di Torino

Abbadessa G; Miele G; Cavalla P; Valentino P; Marfia GA; Signoriello E; Landi D; Bosa C; Vercellino M; De Martino A; Missione R; Sparaco M; Lavorgna L; Lus G; Bonavita S;

Case Report: Covid-19 in Multiple Sclerosis Patients Treated With Ocrelizumab: A Case Series. in Frontiers in neurology / Front Neurol. 2021 Oct 20;12:691616. doi: 10.3389/fneur.2021.691616. eCollection 2021.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Cavalla P; Clerico M; Schillaci V; Bosa C; Alteno A; De Mercanti SF; Vercellino M;

Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders. in Journal of neuroimmunology / J Neuroimmunol. 2020 Feb 15;339:577122. doi: 10.1016/j.jneuroim.2019.577122. Epub 2019 Dec 3.
2020
AOU Città della Salute di Torino

Mengozzi G; Giordana MT; Costantini G; Alteno A; Schillaci V; Pasanisi MB; Bosa C; Limoncelli S; Caropreso P; Cavalla P; Vercellino M;

Antiangiogenic therapy of brain tumors: the role of bevacizumab. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2014 Apr;35(4):507-14. doi: 10.1007/s10072-014-1627-6. Epub 2014 Jan 18.
2014
AOU Città della Salute di Torino

Trevisan E; Bertero L; Bosa C; Magistrello M; Pellerino A; Rudà R; Soffietti R;